Human Genome Editing Science, Ethics, and Governance (2017) / Chapter Skim
Currently Skimming:
References
References
Pages 195-216
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 195... ...
utm_term=.feb89580ad48 (accessed October 18, 2016)
|
From page 196... ...
2016. Genome editing of human germline cells and embryos.
|
From page 197... ...
2016. Treating immunodeficiency through HSC gene therapy.
|
From page 198... ...
2015. Targeted germline modifications in rats using CRISPR/Cas9 and spermatogonial stem cells.
|
From page 199... ...
2016. Ailing fetuses to be treated with stem cells.
|
From page 200... ...
2016. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.
|
From page 201... ...
1993. Application of current statutory authorities to human somatic cell therapy products and gene therapy products; notice.
|
From page 202... ...
1985. Ethical issues in and beyond prospective clinical trials of human gene therapy.
|
From page 203... ...
2014. Targeted genome editing in human re populating haematopoietic stem cells.
|
From page 204... ...
2016. Induced pluripotent stem cells meet genome editing.
|
From page 205... ...
2016. In vitro derivation and propagation of spermatogonial stem cell activity from mouse pluripotent stem cells.
|
From page 206... ...
2015. Biohackers gear up for genome editing.
|
From page 207... ...
2007. Gene targeting in embryonic stem cells scores a knockout in Stockholm.
|
From page 208... ...
2016. In vivo genome editing im proves muscle function in a mouse model of Duchenne muscular dystrophy.
|
From page 209... ...
2010. Final report of the National Academies' Human Embryonic Stem Cell Research Advisory Committee and 2010 amendments to the National Academies' guidelines for human embryonic stem cell research.
|
From page 210... ...
2012. NIH oversight of human gene transfer research involving retroviral, lentiviral, and adeno-associated virus vectors and the role of the NIH Recombinant DNA Advisory Committee.
|
From page 211... ...
2000. Biotechnology on the RAC-FDA/NIH regulation of human gene therapy.
|
From page 212... ...
2015. Robust in vitro induction of human germ cell fate from pluripotent stem cells.
|
From page 213... ...
2013. Hormone suppression with GnRH antagonist promotes spermatogenic recovery from transplanted spermatogonial stem cells in irradi ated cynomolgus monkeys.
|
From page 214... ...
2016. In vivo gene editing in dystrophic mouse muscle and muscle stem cells.
|
From page 215... ...
Human Gene Therapy 2(2)
|
From page 216... ...
2015. Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.